Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 190
Selected: 0
NCT IDTitle
NCT02714621MR-HIFU for Recurrent Gynaecological Cancer
NCT01964677MR-HIFU for Bone Metastases
NCT03857477The BARCODE 1 Study (Full Study): The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening.
NCT06357416The Man Van Project
NCT02375204Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors
NCT02819752PEmbrolizumab Combined With Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck
NCT05810467The Active Surveillance Study
NCT00022191Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer
NCT00053092Combination Chemotherapy With or Without Rituximab in Treating Patients With Mantle Cell Lymphoma
NCT03946202KORTUC Phase II - Intra-tumoural Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer
NCT0024852117-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17-DMAG) in Treating Patients With Metastatic Solid Tumors or Tumors That Cannot Be Removed By Surgery
NCT02955082The BARCODE 2 Study - The Use of Genetic Profiling to Guide Prostate Cancer Treatment
NCT00867347Radiation Therapy or Surgery in Treating Patients Receiving Chemotherapy for Bladder Cancer
NCT03740893PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition With or Without Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Treatment Resistant Residual Triple Negative Breast Cancer
NCT02543905The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and Treatment
NCT02928432SWITCH: Study of the Prednisone to Dexamethasone Change in mCRPC Patients Treated With Abiraterone
NCT01937533Apparent Diffusion Coefficient as a Prognostic Biomarker in Cervical Cancer
NCT03158922The BARCODE 1 Pilot Study
NCT04584853PreOperative Endocrine Therapy for Individualised Care With Abemaciclib
NCT04509986GlobalSurg-CovidSurg Week
NCT02409212Exercise Training as a Novel Primary Therapy for Men With Localised Prostate Cancer
NCT03466034The Role of Hypoxia as a Selective Pressure for TP53 Mutations
NCT00997464An Exploration of Genetic Testing for Prostate Cancer Susceptibility
NCT01337401A Trial of Cediranib in the Treatment of Patients With Alveolar Soft Part Sarcoma (CASPS)
NCT07432932Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients
NCT066322365G-EMERALD: Amivantamab in Malignant Brain Tumours
NCT02753569Imaging NSCLC Treatment Response to Immunotherapy
NCT01881386Lactate Imaging as a Tumour Biomarker
NCT03466944PUMA (Paediatric Osseous Marrow Assessment)
NCT01993979A Phase III Randomised Trial of Peri-Operative Chemotherapy Versus sUrveillance in Upper Tract Urothelial Cancer (POUT)
NCT02305654International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study)
NCT00286117ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years
NCT03592550The eValuation of Image Guidance of Stereotactic Body Radiotherapy Using Ultrasound: Assessment in Liver
NCT05968417Myeloma Novel Drug Discovery Ver 1.2
NCT03256981Stereotactic Body Radiotherapy for the Treatment of OPD
NCT04084145National Unified Renal Translation Research Enterprise - Chronic Kidney Disease
NCT00005586Leucovorin and Fluorouracil Compared With Observation in Treating Patients With Colorectal Cancer That Has Been Surgically Removed
NCT02503917Gynaecologic Organ Segmentation and Motion Tracking Using Ultrasound
NCT00033683Combination Chemotherapy in Treating Women With Resected Breast Cancer
NCT07002320Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer
NCT00140582Primary Rituximab and Maintenance
NCT02389842PIPA: Combination of PI3 Kinase Inhibitors and PAlbociclib
NCT04802590Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma
NCT066302605G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours
NCT02338622Trial of Olaparib in Combination With AZD5363 (ComPAKT)
NCT00045045Positron Emission Tomography in Detecting Testicle Cancer
NCT02296801A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer
NCT03727698Prospective Evaluation of Radiotherapy Using Magnetic Resonance Image Guided Treatment
NCT04151134Evaluation of Tongue Base MucOsectomy & Step sErial Sectioning
NCT02998567Combination Study of Guadecitabine/ASTX727 and Pembrolizumab